Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2686205

N[C@@H](Cc1ccccc1)C(=O)N1CCc2ccc(-c3ccn[nH]3)cc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 5/20 0.41
TSHR P16473 1/20 0.40
UCHL1 P09936 1/20 0.39
DPP4 P27487 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ROCK1 Q13464 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
ROCK2 O75116 1/20 0.38
CYP3A4 P08684 1/20 0.38
HTT P42858 1/20 0.38
RECQL P46063 1/20 0.38
CREBBP Q92793 2/20 0.38
BRD4 O60885 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
PRMT5 O14744 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3792505 0.95 HDAC8 (0.44) HDAC8TSHRUCHL1DPP4NPSR1
Trifluoroacetic Acid SCHEMBL2685752 0.83 HDAC8 (0.43) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL2685605 0.80 HDAC8 (0.47) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL2685606 0.80 HDAC8 (0.47) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL2685396 0.79 DPP4 (0.48) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL2685400 0.79 DPP4 (0.48) HDAC8TSHRUCHL1DPP4NPSR1
Hydrochloric Acid SCHEMBL2686718 0.78 HDAC8 (0.50) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL2683500 0.77 HDAC8 (0.47) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL2683491 0.77 HDAC8 (0.47) HDAC8TSHRUCHL1DPP4NPSR1
SCHEMBL5960867 0.75 EP300 (0.49) HDAC8TSHRNPSR1HTTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785468-B2 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions AMGEN INC. (US) 2014-07-22 US disclosed
US-20120115811-A1 PHENYLANALINE AMIDE DERIVATIVES USEFUL FOR TREATING INSULIN-RELATED DISEASES AND CONDITIONS AMGEN INC. (US) 2012-05-10 US disclosed
WO-2010093849-A2 PHENYLALANINE AMIDE DERIVATIVES USEFUL FOR TREATING INSULIN-RELATED DISEASES AND CONDITIONS AMGEN INC. (US) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115811-A1 PHENYLANALINE AMIDE DERIVATIVES USEFUL FOR TREATING INSULIN-RELATED DISEASES AND CONDITIONS IAPP, INSR, AMY2A HDAC8 2147/4885TSHR 792/4885UCHL1 2654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.